ECSS Space Environment — Radiobiological Risk Assessment (space-systems/ecss/e1012-bio-risk)
Use when the task is the radiobiological risk assessment of ECSS-E-ST-10C §11.5 —
estimating excess cancer risk from mission radiation exposure, categorizing each
uncertainty source by type, deriving risk bounds from the compound uncertainty
factor, and checking the estimate against mission acceptance criteria.
Domain quick reference
- §11.5 structures the risk estimate around three quantities: the accumulated
effective dose (weighted sum of organ equivalent doses using ICRP Publication 103
tissue weighting factors), the risk coefficient that converts effective dose to
excess lifetime cancer probability, and the uncertainty envelope applied to the
point estimate.
- Uncertainty sources are grouped into five categories per the §11.5 taxonomy:
DOSIMETRY (detector calibration, flux measurement), BIOLOGY (radiation biological
effectiveness, DNA repair), MODEL (dose-response extrapolation, risk projection),
EPIDEMIOLOGY (population transfer, baseline cancer rate), and TRANSPORT (shielding
transport, geomagnetic cutoff). Each category carries a multiplicative uncertainty
factor; the compound factor is the product of all applicable category factors.
- The risk bounds are derived symmetrically in log space: upper bound = point
estimate × compound factor, lower bound = point estimate ÷ compound factor. The
assessment is compliant when the upper bound lies at or below the mission
acceptable risk limit; the upper bound drives the determination, not the point
estimate alone.
- Standard ICRP Publication 103 tissue weighting factors sum to 1.0 across the
reference organ set. An effective dose computed from a partial organ set
underestimates true effective dose and must be flagged as incomplete if significant
doses to unrecorded organs are expected.
Workflow
- Collect equivalent doses for each irradiated organ or tissue from the mission
dose assessment and verify that every dose value is non-negative and that the
tissue name appears in the ICRP reference organ set.
- Compute effective dose by multiplying each organ's equivalent dose by the
corresponding ICRP tissue weighting factor and summing over all organs in the
input set; note whether the input covers the full reference organ set.
- Apply the risk coefficient (default: nominal BEIR VII-aligned value for a
mixed-sex reference population, 5.0 × 10⁻⁴ per mSv) to the effective dose to
obtain the point excess cancer risk estimate.
- Identify every applicable uncertainty source for the mission and map each one to
its category (DOSIMETRY, BIOLOGY, MODEL, EPIDEMIOLOGY, or TRANSPORT); reject any
source label not in the recognised taxonomy.
- Compute the compound uncertainty factor as the product of the individual category
factors for all categories represented in the source list.
- Derive the lower and upper risk bounds using the compound factor:
upper = point × factor, lower = point ÷ factor.
- Compare the upper bound against the mission acceptable risk limit; record
compliant when upper bound ≤ limit and the point estimate ≤ limit;
record non-compliant otherwise.
- Report all intermediate quantities (effective dose, point risk, lower bound,
upper bound, compound factor, compliance status) for traceability.
Pitfalls
- Using the point risk estimate directly against the limit without applying the
uncertainty envelope understates the assessed risk; the upper bound of the
uncertainty range is the controlling quantity.
- Treating a partial organ-dose set as a complete effective-dose computation —
organs absent from the input are treated as zero dose, which silently
underestimates effective dose when significant exposure to unrecorded organs is
expected.
- Conflating different uncertainty categories into a single aggregate factor without
tracking which source drove the spread; this prevents identification of which
category dominates risk bound width for shielding or mission-duration trade studies.
- Using a population-specific risk coefficient (for example a single-sex value) on a
crew with a different demographic profile — the nominal mixed-sex coefficient is
conservative for male-only crews but non-conservative for female-heavy crews
relative to female-specific values.
Behavior contract (gate 3)
The effective-dose computation, risk estimation, uncertainty categorization,
risk-bounds derivation, and mission-limit compliance check are exercised by the
gate 3 contract test: scripts/test_e1012_bio_risk.py against
scripts/e1012_bio_risk_logic.py (stdlib unittest, offline). Run:
python3 scripts/test_e1012_bio_risk.py
Compliance
- ECSS standards are freely downloadable (ESA); cite the source and paraphrase per
standards-map.yaml.
- compliance: STANDARDS-REF, gated: false.
1---2name: e1012-bio-risk3description: "Use when run a radiobiological risk assessment for a crewed or uncrewed space mission under ECSS-E-ST-10C §11.5: estimate excess cancer risk from accumulated effective dose, categorize each uncertainty source (dosimetry, biological, model, epidemiological, transport) per the §11.5 uncertainty taxonomy, derive risk bounds using the compound uncertainty factor, and determine whether the risk estimate meets mission-acceptable limits. Trigger: ecss, e-st-10-system-scope, radiobiology, space-radiation-risk, effective-dose, cancer-risk, uncertainty-analysis, dose-response."4license: Apache-2.05compliance: STANDARDS-REF6standards:7 - id: ecss8 reference-only: true9gated: false10domain: space-systems11pack: space-systems12compatibility: "agentskills.io SKILL.md; any SKILL.md host (Claude Code, Hermes, OpenClaw)"13metadata:14 source: https://skillmd.com/skills/ashfordeou/e1012-bio-risk15 domain: space-systems16 subdomain: ecss17 tags: [ecss, e-st-10-system-scope, radiobiology, space-radiation-risk, effective-dose, cancer-risk, uncertainty-analysis, dose-response]18 version: 0.1.019 author: Aero Agent Skills20---2122# ECSS Space Environment — Radiobiological Risk Assessment (space-systems/ecss/e1012-bio-risk)2324Use when the task is the radiobiological risk assessment of ECSS-E-ST-10C §11.5 —25estimating excess cancer risk from mission radiation exposure, categorizing each26uncertainty source by type, deriving risk bounds from the compound uncertainty27factor, and checking the estimate against mission acceptance criteria.2829## Domain quick reference3031- §11.5 structures the risk estimate around three quantities: the accumulated32 effective dose (weighted sum of organ equivalent doses using ICRP Publication 10333 tissue weighting factors), the risk coefficient that converts effective dose to34 excess lifetime cancer probability, and the uncertainty envelope applied to the35 point estimate.36- Uncertainty sources are grouped into five categories per the §11.5 taxonomy:37 DOSIMETRY (detector calibration, flux measurement), BIOLOGY (radiation biological38 effectiveness, DNA repair), MODEL (dose-response extrapolation, risk projection),39 EPIDEMIOLOGY (population transfer, baseline cancer rate), and TRANSPORT (shielding40 transport, geomagnetic cutoff). Each category carries a multiplicative uncertainty41 factor; the compound factor is the product of all applicable category factors.42- The risk bounds are derived symmetrically in log space: upper bound = point43 estimate × compound factor, lower bound = point estimate ÷ compound factor. The44 assessment is compliant when the upper bound lies at or below the mission45 acceptable risk limit; the upper bound drives the determination, not the point46 estimate alone.47- Standard ICRP Publication 103 tissue weighting factors sum to 1.0 across the48 reference organ set. An effective dose computed from a partial organ set49 underestimates true effective dose and must be flagged as incomplete if significant50 doses to unrecorded organs are expected.5152## Workflow53541. Collect equivalent doses for each irradiated organ or tissue from the mission55 dose assessment and verify that every dose value is non-negative and that the56 tissue name appears in the ICRP reference organ set.572. Compute effective dose by multiplying each organ's equivalent dose by the58 corresponding ICRP tissue weighting factor and summing over all organs in the59 input set; note whether the input covers the full reference organ set.603. Apply the risk coefficient (default: nominal BEIR VII-aligned value for a61 mixed-sex reference population, 5.0 × 10⁻⁴ per mSv) to the effective dose to62 obtain the point excess cancer risk estimate.634. Identify every applicable uncertainty source for the mission and map each one to64 its category (DOSIMETRY, BIOLOGY, MODEL, EPIDEMIOLOGY, or TRANSPORT); reject any65 source label not in the recognised taxonomy.665. Compute the compound uncertainty factor as the product of the individual category67 factors for all categories represented in the source list.686. Derive the lower and upper risk bounds using the compound factor:69 upper = point × factor, lower = point ÷ factor.707. Compare the upper bound against the mission acceptable risk limit; record71 compliant when upper bound ≤ limit and the point estimate ≤ limit;72 record non-compliant otherwise.738. Report all intermediate quantities (effective dose, point risk, lower bound,74 upper bound, compound factor, compliance status) for traceability.7576## Pitfalls7778- Using the point risk estimate directly against the limit without applying the79 uncertainty envelope understates the assessed risk; the upper bound of the80 uncertainty range is the controlling quantity.81- Treating a partial organ-dose set as a complete effective-dose computation —82 organs absent from the input are treated as zero dose, which silently83 underestimates effective dose when significant exposure to unrecorded organs is84 expected.85- Conflating different uncertainty categories into a single aggregate factor without86 tracking which source drove the spread; this prevents identification of which87 category dominates risk bound width for shielding or mission-duration trade studies.88- Using a population-specific risk coefficient (for example a single-sex value) on a89 crew with a different demographic profile — the nominal mixed-sex coefficient is90 conservative for male-only crews but non-conservative for female-heavy crews91 relative to female-specific values.9293## Behavior contract (gate 3)9495The effective-dose computation, risk estimation, uncertainty categorization,96risk-bounds derivation, and mission-limit compliance check are exercised by the97gate 3 contract test: scripts/test_e1012_bio_risk.py against98scripts/e1012_bio_risk_logic.py (stdlib unittest, offline). Run:99python3 scripts/test_e1012_bio_risk.py100101## Compliance102103- ECSS standards are freely downloadable (ESA); cite the source and paraphrase per104 standards-map.yaml.105- compliance: STANDARDS-REF, gated: false.